Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
14.93
-0.28 (-1.84%)
At close: Jun 20, 2025, 4:00 PM
14.93
0.00 (0.00%)
After-hours: Jun 20, 2025, 4:04 PM EDT
Inhibrx Biosciences Market Cap
Inhibrx Biosciences has a market cap or net worth of $216.13 million as of June 20, 2025. Its market cap has decreased by -13.25% in one year.
Market Cap
216.13M
Enterprise Value
106.14M
1-Year Change
-13.25%
Ranking
Category
Stock Price
$14.93
Market Cap Chart
Since the IPO on May 29, 2024, Inhibrx Biosciences's market cap has increased from $198.24M to $216.13M, an increase of 9.02%. That is a compound annual growth rate of 8.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 20, 2025 | 216.13M | -3.05% |
| Dec 31, 2024 | 222.93M | 12.46% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 706.07B |
| Johnson & Johnson | 364.26B |
| Novo Nordisk | 334.60B |
| AbbVie | 328.90B |
| UnitedHealth Group | 280.94B |
| Abbott Laboratories | 231.45B |
| Novartis AG | 229.92B |
| AstraZeneca | 223.18B |